OCT Guided Magmaris RMS in STEMI (BESTMAG)
Optical Coherence Guided Treatment of ST-segment Elevation Myocardial Infarction With the Drug-eluting Resorbable Magnesium Scaffold: the BEST- MAG Multicentre Study. (BElgian ST-segment Elevation Myocardial Infarction Treatment With Resorbable MAGnesium Scaffold).
Sponsor: CHU de Charleroi
This NA trial investigates STEMI and is currently actively recruiting participants. CHU de Charleroi leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Recruiting NA
-
Aug 2024 — Sep 2024 [monthly]
Recruiting NA
Status: Unknown → Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jun 2023 — Jul 2024 [monthly]
Unknown Status NA
-
Nov 2022 — Jun 2023 [monthly]
Unknown Status NA
▶ Show 3 earlier versions
-
Mar 2022 — Nov 2022 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Mar 2022 [monthly]
Recruiting NA
-
Jun 2019 — Jan 2021 [monthly]
Recruiting NA
First recorded
Feb 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CHU de Charleroi
- Centre Hospitalier Régional de la Citadelle
- Centre Hospitalier Universitaire Saint Pierre
- Centre Hospitalier Universitaire UCLouvain Namur
- Jolimont
- Le centre hospitalier EpiCURA
- Universitair Ziekenhuis Brussel
- Universitaire Ziekenhuizen KU Leuven
- University Hospital St Luc, Brussels
- Ziekenhuis Oost-Limburg
For direct contact, visit the study record on ClinicalTrials.gov .